UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007236 |
|---|---|
| Receipt number | R000008527 |
| Scientific Title | A multicenter phase II trial of TS-1+oxaliplatin+panitumumab as first-line treatment in patients with kras-wild type unresectable advanced colorectal liver metastasis. |
| Date of disclosure of the study information | 2012/02/07 |
| Last modified on | 2019/04/09 12:42:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/02/07 00:12:40 | ||
| 2 | Update | 2012/02/07 00:15:52 | Date of disclosure of the study information |
|
| 3 | Update | 2012/05/30 18:34:46 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2012/05/30 18:37:05 | Recruitment status |
|
| 5 | Update | 2012/07/08 15:49:07 | Recruitment status |
|
| 6 | Update | 2013/01/05 10:55:15 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2014/02/12 09:15:11 | Email |
|
| 8 | Update | 2018/06/25 14:57:12 | Recruitment status |
|
| 9 | Update | 2019/04/09 12:36:52 | Date of IRB Last follow-up date |
|
| 10 | Update | 2019/04/09 12:38:28 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 11 | Update | 2019/04/09 12:42:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
